신경 진단 시장 보고서 : 동향, 예측 및 경쟁 분석(-2030년)

Neurodiagnostics Trends and Forecast

The future of the global neurodiagnostics market looks promising with opportunities in the hospital and surgery center, neurology center, ambulatory care center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets. The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increased prevalence of neurological diseases and disorders, growing patient emphasis on accurate and timely disease diagnosis, as well as, the advancemenet in genomics and proteomics for neurodegenerative disorder diagnosis.

A more than 150-page report is developed to help in your business decisions.

Neurodiagnostics by Segment

The study includes a forecast for the global neurodiagnostics by product, condition, end use, and region.

Neurodiagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Introduction
• Diagnostic And Imaging Systems
• Clinical Testing Instruments
• Reagents & Consumables

Neurodiagnostics Market by Condition [Shipment Analysis by Value from 2018 to 2030]:

• Neuro Degenerative Diseases
• Epilepsy
• Stroke
• Headache Disorders
• Sleep Disorders
• Others

Neurodiagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals And Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes
• Others

Neurodiagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Neurodiagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurodiagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurodiagnostics companies profiled in this report include-

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon
• Hitachi
• Lifelines Neuro Company
• Natus Medical
• Hoffman-La Roche
• FUJIFILM Holdings
• Mitsar

Neurodiagnostics Market Insights

Lucintel forecasts that neuro degenerative disease will remain the largest segment over the forecast period due to the prevalence of traumatic brain injuries, dementia, parkinson's disease, and huntington's disease is rising.

North America will remain the largest region over the forecast period due to the presence of a well-developed healthcare system, widespread acceptance of modern neurodiagnostic instruments among medical professionals, and complete accessibility to sophisticated neurodiagnostic technologies.

Features of the Global Neurodiagnostics Market

Market Size Estimates: Neurodiagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neurodiagnostics market size by product, condition, end use, and region in terms of value ($B).

Regional Analysis: Neurodiagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, condition, end use, and regions for the neurodiagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurodiagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the neurodiagnostics market size?

Answer: The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030.

Q2. What is the growth forecast for neurodiagnostics market?

Answer: The global neurodiagnostics market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the neurodiagnostics market?

Answer: The major drivers for this market are increased prevalence of neurological diseases and disorders, growing patient emphasis on accurate and timely disease diagnosis, as well as, the advancemenet in genomics and proteomics for neurodegenerative disorder diagnosis.

Q4. What are the major segments for neurodiagnostics market?

Answer: The future of the global neurodiagnostics market looks promising with opportunities in the hospital and surgery center, neurology center, ambulatory care center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets.

Q5. Who are the key neurodiagnostics market companies?

Answer: Some of the key neurodiagnostics companies are as follows.

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon
• Hitachi
• Lifelines Neuro Company
• Natus Medical
• Hoffman-La Roche
• FUJIFILM Holdings
• Mitsar

Q6. Which neurodiagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that neuro degenerative disease will remain the largest segment over the forecast period due to the prevalence of traumatic brain injuries, dementia, parkinson's disease, and huntington's disease is rising.

Q7. In neurodiagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the presence of a well-developed healthcare system, widespread acceptance of modern neurodiagnostic instruments among medical professionals, and complete accessibility to sophisticated neurodiagnostic technologies.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the neurodiagnostics market by product (introduction, diagnostic and imaging systems, clinical testing instruments, and reagents & consumables), condition (neuro degenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and others), end use (hospitals and surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories & imaging centers, research laboratories & academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neurodiagnostics Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Neurodiagnostics Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Neurodiagnostics Market by Product
  • 3.3.1: Introduction
  • 3.3.2: Diagnostic and Imaging Systems
  • 3.3.3: Clinical Testing Instruments
  • 3.3.4: Reagents & Consumables
• 3.4: Global Neurodiagnostics Market by Condition
  • 3.4.1: Neuro Degenerative Diseases
  • 3.4.2: Epilepsy
  • 3.4.3: Stroke
  • 3.4.4: Headache Disorders
  • 3.4.5: Sleep Disorders
  • 3.4.6: Others
• 3.5: Global Neurodiagnostics Market by End Use
  • 3.5.1: Hospitals and Surgery Centers
  • 3.5.2: Neurology Centers
  • 3.5.3: Ambulatory Care Centers
  • 3.5.4: Diagnostic Laboratories & Imaging Centers
  • 3.5.5: Research Laboratories & Academic Institutes
  • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Neurodiagnostics Market by Region
• 4.2: North American Neurodiagnostics Market
  • 4.2.1: North American Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
  • 4.2.2: North American Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
• 4.3: European Neurodiagnostics Market
  • 4.3.1: European Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
  • 4.3.2: European Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
• 4.4: APAC Neurodiagnostics Market
  • 4.4.1: APAC Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
  • 4.4.2: APAC Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
• 4.5: ROW Neurodiagnostics Market
  • 4.5.1: ROW Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
  • 4.5.2: ROW Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Neurodiagnostics Market by Product
  • 6.1.2: Growth Opportunities for the Global Neurodiagnostics Market by Condition
  • 6.1.3: Growth Opportunities for the Global Neurodiagnostics Market by End Use
  • 6.1.4: Growth Opportunities for the Global Neurodiagnostics Market by Region
• 6.2: Emerging Trends in the Global Neurodiagnostics Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Neurodiagnostics Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurodiagnostics Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GE Healthcare
• 7.2: Siemens Healthineers
• 7.3: Philips Healthcare
• 7.4: Canon
• 7.5: Hitachi
• 7.6: Lifelines Neuro Company
• 7.7: Natus Medical
• 7.8: Hoffman-La Roche
• 7.9: FUJIFILM Holdings
• 7.10: Mitsar